Impact BioMedical Correlations

IBO Stock  USD 0.46  0  0.22%   
The current 90-days correlation between Impact BioMedical and Neurosense Therapeutics is -0.03 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Impact BioMedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Impact BioMedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Impact BioMedical Correlation With Market

Significant diversification

The correlation between Impact BioMedical and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Impact BioMedical and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical guide.

Moving against Impact Stock

  0.47PPERY Bank Mandiri Persero Earnings Call This WeekPairCorr
  0.38OABI OmniAb IncPairCorr
  0.57TLK Telkom Indonesia TbkPairCorr
  0.52TLKMF Telkom Indonesia TbkPairCorr
  0.51VASO Vaso CorpPairCorr
  0.37DAR Darling IngredientsPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

XBIOAIM
XBIOXTLB
ADILMLEC
XBIOMLEC
CYCNAIM
ADILBCLI
  

High negative correlations

XTLBTCRT
TCRTBCLI
XBIOTCRT
MLECTCRT
XTLBQNRX
TCRTAIM

Risk-Adjusted Indicators

There is a big difference between Impact Stock performing well and Impact BioMedical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Impact BioMedical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NRSN  4.51 (0.16) 0.00  1.40  0.00 
 12.82 
 34.62 
AIM  4.42 (1.16) 0.00 (0.29) 0.00 
 8.24 
 29.72 
BCLI  3.54 (0.12) 0.00  0.19  0.00 
 9.09 
 24.01 
TCRT  4.44  0.12  0.02  0.17  5.61 
 9.61 
 24.31 
MLEC  9.02  0.35  0.04  0.16  10.42 
 15.63 
 152.55 
CYCN  4.51 (0.44) 0.00 (0.22) 0.00 
 11.11 
 55.81 
QNRX  6.78 (0.02) 0.00  0.09  0.00 
 18.69 
 77.47 
ADIL  2.95 (0.78) 0.00 (0.47) 0.00 
 5.56 
 16.67 
XTLB  4.68 (0.22) 0.00 (0.53) 0.00 
 7.79 
 69.50 
XBIO  3.35 (0.68) 0.00 (0.40) 0.00 
 4.76 
 18.79 

Impact BioMedical Corporate Executives

Elected by the shareholders, the Impact BioMedical's board of directors comprises two types of representatives: Impact BioMedical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Impact. The board's role is to monitor Impact BioMedical's management team and ensure that shareholders' interests are well served. Impact BioMedical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Impact BioMedical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Todd CPASecretary CFOProfile